A NEW FUNCTIONAL CYP3A4 POLYMORPHISM (CYP3A4*22) IS ASSOCIATED WITH INCREASED RISK OF DELAYED GRAFT FUNCTION AND WORSE RENAL FUNCTION IN CYCLOSPORIN-TREATED KIDNEY TRANSPLANT RECIPIENTS.

被引：0
|
作者：
Elens, L. [1 ]
Bouarmar, R. [2 ]
Hesselink, D. A. [3 ]
Haufroid, V. [4 ]
van Gelder, T.
van Schaik, R. H. [1 ,3 ]
机构：
[1] Erasmus MC, Dept Clin Chem, Rotterdam, Netherlands
[2] Erasmus MC, Dept Hosp Pharm, Rotterdam, Netherlands
[3] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands
[4] Catholic Univ Louvain, Louvain Ctr Toxicol & Appl Pharmacol, B-1200 Brussels, Belgium
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2012年 / 91卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S107 / S107
页数：1
相关论文
共 50 条
  • [31] Cyp3A4, Cyp3A5, and MDR-1 genetic influences on tacrolimus pharmacokinetics in renal transplant recipients
    Roy, Jean Nicholas
    Barama, Azemi
    Poirier, Charles
    Vinet, Bernard
    Roger, Michel
    PHARMACOGENETICS AND GENOMICS, 2006, 16 (09): : 659 - 665
  • [32] Influence of CYP3A4*22 and CYP3A5*3 genetic polymorphisms on tacrolimus pharmacokinetics in adult renal transplant patients
    Salvador, Pilar
    Outeda, Maria
    Pedreira, Isaura
    Fernandez, Constantino
    Alonso, Angel
    Martin, Isabel
    TRANSPLANTATION, 2016, 100 (07) : S709 - S709
  • [33] Alterations of CYP3A4 and P-glycoprotein activity in vivo with time in renal graft recipients
    Lemahieu, WPD
    Maes, BD
    Verbeke, K
    Vanrenterghem, YFC
    KIDNEY INTERNATIONAL, 2004, 66 (01) : 433 - 440
  • [34] Association of CYP3A4*18B and CYP3A5*3 polymorphism with cyclosporine-related liver injury in Chinese renal transplant recipients
    Xin, Hua-wen
    Liu, Hui-ming
    Li, Yuan-qi
    Huang, Hui
    Zhang, Li
    Yu, Ai-rong
    Wu, Xiao-chun
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2014, 52 (06) : 497 - 503
  • [35] Influence of Cyp3A4, Cyp3A5 and ABCB1 Polymorphisms on Tacrolimus Concentrations and Rejection Risk in Indian Kidney Transplant Recipients
    Mukkavilli, Kamal Kiran
    Khan, Mohammed Shoeb A.
    Donakonda, Arun Kumar
    Gangisetty, Suma Rama Gopal
    Poojaveli, Dileena
    INDIAN JOURNAL OF TRANSPLANTATION, 2024, 18 (01) : 42 - 45
  • [36] The CYP3A4*22 C>T single nucleotide polymorphism is associated with reduced midazolam and tacrolimus clearance in stable renal allograft recipients
    H de Jonge
    L Elens
    H de Loor
    R H van Schaik
    D R J Kuypers
    The Pharmacogenomics Journal, 2015, 15 : 144 - 152
  • [37] ASSOCIATION OF CYP3A4☆18B AND CYP3A5☆3 POLYMORPHISM WITH CYCLOSPORINE-RELATED LIVER INJURY IN CHINESE RENAL TRANSPLANT RECIPIENTS
    Xin, H.
    Yu, A.
    Wu, X.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2014, 115 : 60 - 60
  • [38] Impact of the CYP3A4*1G Polymorphism and Its Combination with CYP3A5 Genotypes on Tacrolimus Pharmacokinetics in Japanese Renal Transplant Recipients
    Satoh, S.
    Miura, M.
    Kagaya, H.
    Saito, M.
    Numakura, K.
    Tsuchiya, N.
    Habuchi, T.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 83 - 83
  • [39] Effect of a new functional CYP3A4 polymorphism on tacrolimus dose requirement and trough blood levels in stable renal transplant patients
    Elens, L.
    van Schaik, R.
    Panin, N.
    De Meyer, M.
    Wallemacq, P.
    Lison, D.
    Mourad, M.
    Haufroid, V
    THERAPEUTIC DRUG MONITORING, 2011, 33 (04) : 507 - 507
  • [40] Effect of a new functional CYP3A4 polymorphism on cyclosporine dose requirement and trough blood levels in stable renal transplant patients
    Elens, L.
    van Schaik, R.
    Panin, N.
    De Meyer, M.
    Wallemacq, P.
    Lison, D.
    Mourad, M.
    Haufroid, V
    THERAPEUTIC DRUG MONITORING, 2011, 33 (04) : 506 - 507
12345